INTRODUCTION
Central nervous system (CNS) lymphoma is a rare presentation of post-transplantation lymphoproliferative disorder (PTLD). Outcomes are often poor and diagnosis late.
AIMS
To perform an ethically approved single center review of presentations, management and outcomes of CNS lymphomas in kidney transplant patients transplanted 1968 to 2015.
METHODOLOGY
We identified 90 adult patients with a PTLD diagnosis in our unit from a transplant unit that has performed over 4000 implantations. 6/90 (7%) presented with CNS involvement. Retrospective case based review was performed.
RESULTS

CONCLUSION:
CNS involving PTLD is uncommon and occurs late. Despite disease being EBV positive, blood and CSF may have undetectable or low level viral loads at diagnosis. The high prevalence of patients on MMF mono-therapy at diagnosis is of note, and may lead to B cell depletion and low EBV viremia but may be involved in pathogenesis.
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